Neoplasms, Connective and Soft Tissue  >>  paclitaxel  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
paclitaxel / Generic mfg.
NCT00003128: Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus

Completed
3
166
US
filgrastim, ifosfamide, paclitaxel
Gynecologic Oncology Group, National Cancer Institute (NCI), Eastern Cooperative Oncology Group
Sarcoma
02/07
 
NCT00003350: Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma

Completed
3
240
US
paclitaxel, Anzatax, Asotax, TAX, Taxol, pegylated liposomal doxorubicin hydrochloride, CAELYX, Dox-SL, DOXIL, doxorubicin hydrochloride liposome, LipoDox, laboratory biomarker analysis, quality-of-life assessment, quality of life assessment
National Cancer Institute (NCI)
AIDS-related Kaposi Sarcoma
03/07
 

Download Options